Azenta, Inc. (NASDAQ:AZTA – Get Free Report) gapped down before the market opened on Thursday after Needham & Company LLC lowered their price target on the stock from $75.00 to $69.00. The stock had previously closed at $54.07, but opened at $51.15. Needham & Company LLC currently has a buy rating on the stock. Azenta shares last traded at $49.53, with a volume of 87,243 shares changing hands.
A number of other analysts have also commented on the stock. Evercore ISI decreased their price target on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research note on Thursday, April 4th. B. Riley upped their target price on shares of Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Jefferies Financial Group started coverage on Azenta in a research note on Thursday, April 4th. They set a “hold” rating and a $64.00 price target for the company. Finally, Stephens reissued an “equal weight” rating and set a $70.00 price objective on shares of Azenta in a report on Thursday, February 8th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $68.40.
Get Our Latest Research Report on Azenta
Hedge Funds Weigh In On Azenta
Azenta Stock Down 2.9 %
The company has a market cap of $2.93 billion, a P/E ratio of -169.38 and a beta of 1.51. The company’s 50-day moving average is $57.43 and its two-hundred day moving average is $59.17.
Azenta (NASDAQ:AZTA – Get Free Report) last released its earnings results on Wednesday, May 8th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. The firm had revenue of $159.13 million during the quarter, compared to the consensus estimate of $159.89 million. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The company’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.06) EPS. On average, analysts anticipate that Azenta, Inc. will post 0.27 EPS for the current fiscal year.
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
- Five stocks we like better than Azenta
- Are Penny Stocks a Good Fit for Your Portfolio?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is the Dow Jones Industrial Average (DJIA)?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.